About

Publications While At HealthPartners

selected publications

Journal Article

Continuous glucose monitoring-based time-in-range using insulin glargine 300 units/ml versus insulin degludec 100 units/ml in type 1 diabetes: the head-to-head randomized controlled InRange trial. 

Diabetes, Obesity & Metabolism. 2023

InRange: comparison of the second-generation basal insulin analogues glargine 300 U/mL and degludec 100 U/mL in persons with type 1 diabetes using continuous glucose monitoring-study design. 

Diabetes Therapy. 2020

Contact

full name

V. Pilorget

Quick Info

 

Collaboration

Co-author network

Map of science